He has been a faculty member at the University of Wisconsin-Madison, and the University of Tennessee, Memphis
For optimal results, follow the suggested dosage
What Studies Have NOT Demonstrated in Humans Despite community claims, no controlled human trial has demonstrated: A specific body fat percentage reduction attributable to LR3 IGF-1 cycling A specific lean mass gain figure for the standard 10-day-on / 4-week-off pattern Cardiovascular safety endpoints across repeated cycles Long-term cancer-incidence data for cycled LR3 IGF-1 use Epidemiological data on chronically elevated endogenous IGF-1 has raised theoretical cancer concerns (Yoshida & Delafontaine, 2020), and that concern is one reason community protocols favor short, spaced cycles rather than continuous use
G., Dyson, P
By maintaining open communication with your medical team, you can navigate the complexities of GLP-1-related hair loss and work towards a solution that supports both your weight management and hair health goals
multiple agent therapy with sequential administration of the agents, produces a synergistic effect